Our functional study highlights that the dysregulation of NF‐κB signalling pathway triggered by excessive ROS resulting from OXPHOS defects may be the underlying pathogenic mechanism of mitochondrial myopathy caused by OXA1L variants, shedding new lights on understanding these processes and developing new therapies. The gene discussed is NFKB1; the disease is Mitochondrial myopathy.